BioCentury | Apr 18, 2019
Emerging Company Profile

Phenomic AI: phenotypic screening for antibody discovery

...raised: $2.5 million Investors: Layer 6 AI, iNovia Capital, Cantos, Hemi Ventures, Garage Technology Ventures, MaRS Innovation...
BioCentury | Apr 12, 2019
Emerging Company Profile

Bright Angel: New hope against fungal resistance

...focus: Infectious Clinical status: Preclinical Founded: 2017 by Leah Cowen, Luke Whitesell, Schrödinger LLC and MaRS Innovation...
...Corporate partners: Schrödinger LLC Number of employees: Undisclosed Funds raised: C$1 million ($0.75 million) Investors: MaRS Innovation...
...Therapeutics Inc., Toronto, Ont. F2G Ltd., Eccles, U.K. Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), West Conshohocken, Pa. MaRS Innovation...
BioCentury | Oct 27, 2017
Company News

Evotec, MaRS Innovation open LAB150

...In September, MaRS Innovation (Toronto, Ontario) and Evotec AG (Xetra:EVT) partnered to open the Toronto-based LAB150 accelerator...
...shorten the drug discovery timeline by designating $75,000-$400,000 to 3-5 projects a year emerging from MaRS innovation’s...
...by the accelerator. Evotec AG (Xetra:EVT), Hamburg, Germany MaRS Innovation , Toronto, Ontario Business: Pharmaceuticals Alicia Parker Evotec AG MaRS Innovation...
BioCentury | Feb 10, 2017
Financial News

Fibrocor completes venture financing

...Toronto, Ontario) raised C$2.8 million ($2.1 million) in a venture round with Evotec AG and MaRS Innovation...
BioCentury | Nov 18, 2016
Emerging Company Profile

Suppressing somatostatin

...in healthy individuals and Type I diabetes patients. The newco spun out of CDRD and MaRS Innovation...
...Technology: Somatostatin receptor 2 (SSTR2) antagonists Disease focus: Endocrine/metabolic Clinical status: Preclinical Founded: 2014 by MaRS Innovation...
...of Toronto Corporate partners: None Number of employees: 5 Funds raised: $2 million Investors: CDRD, MaRS Innovation...
BioCentury | Oct 20, 2016
Finance

3Q16 Public-Private Partnership Roundup

...hypoglycemia in patients with Type I diabetes. Zucara is a 2015 spinout of CDRD and MaRS Innovation...
...Research in Immunology and Cancer - Commercialization of Research (IRICoR) projects co-developed with CDRD or MaRS Innovation...
BioCentury | Feb 22, 2016
Financial News

ScarX completes venture financing

...Type: Venture financing Raised: C$2 million ($1.4 million) Investors: Accel-Rx Health Sciences Accelerator; BDC Capital; MaRS Innovation...
BioCentury | Oct 5, 2015
Financial News

Encycle Therapeutics completes venture financing

...Raised: C$2.9 million ($2.1 million) Investors: Takeda Ventures Inc.; Accel-Rx Health Sciences Accelerator; BDC Capital; MaRS Innovation...
BioCentury | Sep 9, 2015
Company News

J&J to launch JLABS incubator in Toronto

...spring 2016. J&J is launching the incubator in collaboration with the University of Toronto , MaRS Innovation...
...Ministry of Economic Development, Employment and Infrastructure. In June, J&J expanded an existing collaboration with MaRS Innovation...
BioCentury | Aug 24, 2015
Finance

Versant bites at the apple

...The key difference between the two regions, he said, is lab space. Whereas Toronto has MaRS Innovation...
...Vancouver, B.C. Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France MaRS Innovation...
Items per page:
1 - 10 of 42
BioCentury | Apr 18, 2019
Emerging Company Profile

Phenomic AI: phenotypic screening for antibody discovery

...raised: $2.5 million Investors: Layer 6 AI, iNovia Capital, Cantos, Hemi Ventures, Garage Technology Ventures, MaRS Innovation...
BioCentury | Apr 12, 2019
Emerging Company Profile

Bright Angel: New hope against fungal resistance

...focus: Infectious Clinical status: Preclinical Founded: 2017 by Leah Cowen, Luke Whitesell, Schrödinger LLC and MaRS Innovation...
...Corporate partners: Schrödinger LLC Number of employees: Undisclosed Funds raised: C$1 million ($0.75 million) Investors: MaRS Innovation...
...Therapeutics Inc., Toronto, Ont. F2G Ltd., Eccles, U.K. Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL), West Conshohocken, Pa. MaRS Innovation...
BioCentury | Oct 27, 2017
Company News

Evotec, MaRS Innovation open LAB150

...In September, MaRS Innovation (Toronto, Ontario) and Evotec AG (Xetra:EVT) partnered to open the Toronto-based LAB150 accelerator...
...shorten the drug discovery timeline by designating $75,000-$400,000 to 3-5 projects a year emerging from MaRS innovation’s...
...by the accelerator. Evotec AG (Xetra:EVT), Hamburg, Germany MaRS Innovation , Toronto, Ontario Business: Pharmaceuticals Alicia Parker Evotec AG MaRS Innovation...
BioCentury | Feb 10, 2017
Financial News

Fibrocor completes venture financing

...Toronto, Ontario) raised C$2.8 million ($2.1 million) in a venture round with Evotec AG and MaRS Innovation...
BioCentury | Nov 18, 2016
Emerging Company Profile

Suppressing somatostatin

...in healthy individuals and Type I diabetes patients. The newco spun out of CDRD and MaRS Innovation...
...Technology: Somatostatin receptor 2 (SSTR2) antagonists Disease focus: Endocrine/metabolic Clinical status: Preclinical Founded: 2014 by MaRS Innovation...
...of Toronto Corporate partners: None Number of employees: 5 Funds raised: $2 million Investors: CDRD, MaRS Innovation...
BioCentury | Oct 20, 2016
Finance

3Q16 Public-Private Partnership Roundup

...hypoglycemia in patients with Type I diabetes. Zucara is a 2015 spinout of CDRD and MaRS Innovation...
...Research in Immunology and Cancer - Commercialization of Research (IRICoR) projects co-developed with CDRD or MaRS Innovation...
BioCentury | Feb 22, 2016
Financial News

ScarX completes venture financing

...Type: Venture financing Raised: C$2 million ($1.4 million) Investors: Accel-Rx Health Sciences Accelerator; BDC Capital; MaRS Innovation...
BioCentury | Oct 5, 2015
Financial News

Encycle Therapeutics completes venture financing

...Raised: C$2.9 million ($2.1 million) Investors: Takeda Ventures Inc.; Accel-Rx Health Sciences Accelerator; BDC Capital; MaRS Innovation...
BioCentury | Sep 9, 2015
Company News

J&J to launch JLABS incubator in Toronto

...spring 2016. J&J is launching the incubator in collaboration with the University of Toronto , MaRS Innovation...
...Ministry of Economic Development, Employment and Infrastructure. In June, J&J expanded an existing collaboration with MaRS Innovation...
BioCentury | Aug 24, 2015
Finance

Versant bites at the apple

...The key difference between the two regions, he said, is lab space. Whereas Toronto has MaRS Innovation...
...Vancouver, B.C. Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France MaRS Innovation...
Items per page:
1 - 10 of 42